Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

BACKGROUND: Agomelatine, the first melatonergic antidepressant, has been postulated to enhance the dopaminergic activity at the central nervous system by 5-hydroxytryptamine receptor type 2C (5-HT2C) antagonism, yet the impact of melatonergic agonism on this pathway is unclear. Previous studies empl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornaro, Michele, Bandini, Fabio, Cestari, Luca, Cordano, Christian, Ogliastro, Carla, Albano, Claudio, De Berardis, Domenico, Martino, Matteo, Escelsior, Andrea, Rocchi, Giulio, Fornaro, Pantaleo, De Pasquale, Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038423/
https://www.ncbi.nlm.nih.gov/pubmed/24899809
http://dx.doi.org/10.2147/NDT.S63459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038423/
https://www.ncbi.nlm.nih.gov/pubmed/24899809
http://dx.doi.org/10.2147/NDT.S63459

Ejemplares similares